SK Chemicals, Institutional Investors Sold Net 53,742 Shares in Last 5 Days... Stock Price 414,500 KRW (-0.12%)
As of 2:31 PM on the 2nd, SK Chemicals is trading at 414,500 KRW, down 0.12% from the previous day. The trading volume is 295,047 shares, which is 36.59% of the previous day's volume. SK Chemicals is known as a manufacturer of eco-friendly materials, energy, and biopharmaceuticals.
On September 1st, researcher Dalmi Lee from SK Securities stated, "Due to COVID-19, SK Chemicals has secured CMO orders from AstraZeneca and Novavax, increasing the value of its vaccines. Production of AstraZeneca's volume began in Q3 2020, expected to drive vaccine performance. Additionally, due to increased demand for flu vaccines, Q3 2020 vaccine performance is expected to reach an all-time high. It is also anticipated that the Phase 3 clinical trial results of client companies will be promising. The subsidiary, SK Bioscience, is scheduled to go public next year, which is expected to further increase value." He set SK Chemicals' target price at 500,000 KRW.
Over the past five days, individual investors have net purchased 1,553 shares of SK Chemicals, while foreigners and institutions have net purchased 52,328 shares and net sold 53,742 shares, respectively.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
